Icon
+91 94997 68112
Login Register

ZYNRELEF KIT - (60MG/2.3ML;1.8MG/2.3ML, 200MG/7ML;6MG/7ML, 300MG/10.5ML;9MG/10.5ML, 400MG/14ML;12MG/14ML)

BUPIVACAINE; MELOXICAM None
60MG/2.3ML;1.8MG/2.3ML, 200MG/7ML;6MG/7ML, 300MG/10.5ML;9MG/10.5ML, 400MG/14ML;12MG/14ML
Less Than $1000 mn
None None
None None
None None
ZYNRELEF contains bupivacaine, an amide local anesthetic, and meloxicam, a nonsteroidal anti-inflammatory drug (NSAID), and is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.
Yes
ZYNRELEF KIT Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.